Shenzhen YHLO Biotech Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shenzhen YHLO Biotech Co., Ltd.

Why is Shenzhen YHLO Biotech Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -14.36% and Operating profit at -35.70% over the last 5 years

With a fall in Net Sales of -25.9%, the company declared Very Negative results in Mar 25

The company has declared negative results for the last 9 consecutive quarters
The company has declared negative results in Mar 23 after 2 consecutive negative quarters
ROCE(HY) Lowest at 9.1%
INVENTORY TURNOVER RATIO(HY) Lowest at 1.34%
DEBTORS TURNOVER RATIO(HY) Lowest at 3.84%

With ROE of 6.88%, it has a expensive valuation with a 3.05 Price to Book Value

Over the past year, while the stock has generated a return of -16.03%, its profits have fallen by -46.6%

Below par performance in long term as well as near term

Along with generating -16.03% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shenzhen YHLO Biotech Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Shenzhen YHLO Biotech Co., Ltd.

-16.03%

-1.82

24.96%

China Shanghai Composite

24.27%

1.73

14.05%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-14.36%

EBIT Growth (5y)

-35.70%

EBIT to Interest (avg)

50.60

Debt to EBITDA (avg)

0.13

Net Debt to Equity (avg)

0.09

Sales to Capital Employed (avg)

0.61

Tax Ratio

11.06%

Dividend Payout Ratio

39.64%

Pledged Shares

Institutional Holding

ROCE (avg)

24.88%

ROE (avg)

18.68%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.05

EV to EBIT

40.24

EV to EBITDA

17.40

EV to Capital Employed

2.81

EV to Sales

4.59

PEG Ratio

Dividend Yield

ROCE (Latest)

6.99%

ROE (Latest)

6.88%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

Bearish

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -16.93% (YoY

-29What is not working for the Company

ROCE(HY)

Lowest at 9.1%

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.34%

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.84%

INTEREST(Q)

At CNY 4.83 MM has Grown at 26.04%

INTEREST COVERAGE RATIO(Q)

Lowest at 966.89

NET SALES(Q)

Lowest at CNY 415.86 MM

OPERATING PROFIT(Q)

Lowest at CNY 46.66 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 11.22 %

PRE-TAX PROFIT(Q)

Lowest at CNY 50.23 MM

NET PROFIT(Q)

Lowest at CNY 47.73 MM

EPS(Q)

Lowest at CNY 0.02

Here's what is working for Shenzhen YHLO Biotech Co., Ltd.

Raw Material Cost

Fallen by -16.93% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shenzhen YHLO Biotech Co., Ltd.

Interest

At CNY 4.83 MM has Grown at 26.04%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 966.89

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Inventory Turnover Ratio

Lowest at 1.34% and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 3.84% and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Net Sales

Lowest at CNY 415.86 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit

Lowest at CNY 46.66 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 11.22 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at CNY 50.23 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Pre-Tax Profit

Fallen at -34.87%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit

Lowest at CNY 47.73 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

Net Profit

Fallen at -32.74%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS

Lowest at CNY 0.02

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Non Operating Income

Highest at CNY 0.66 MM

in the last five periods

MOJO Watch

Increased income from non business activities may not be sustainable

Non Operating income